Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 24, 2023
Discovery & Translation

ROTACs for transmembrane protein degradation; plus AntlerA’s lung regeneration therapy and more

BioCentury’s roundup of translational news
BioCentury | Sep 23, 2022
Discovery & Translation

PROTAC logic continues to evolve

New publications highlight bispecific antibody degraders as a way to eliminate a cell surface target
BioCentury | May 31, 2012
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 5 of 5